Propanc Biopharma, Inc. PPCB
At closeNov 11, 2026, 7:43 PM EST
After hours · Nov 11, 7:43 PM ET
- YTD
- -98.63%
- 1 year
- -99.12%
PPCB free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-5,687,568 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | -5,687,568 | -5,282,400 | Not meaningful |
| FY 2025 | 2025-06-30 | -405,168 | 529,950 | Not meaningful |
| FY 2024 | 2024-06-30 | -935,118 | 170,133 | Not meaningful |
| FY 2023 | 2023-06-30 | -1,105,251 | 331,053 | Not meaningful |
| FY 2022 | 2022-06-30 | -1,436,304 | -291,040 | Not meaningful |
| FY 2021 | 2021-06-30 | -1,145,264 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-27T06:00:35.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.